Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.

FDA Approves Imlunestrant (Inluriyo) for Certain Hormone Receptor-Positive Breast Cancers

imlunestrant image.jpg

Imlunestrant is a hormonal therapy medicine used to treat advanced-stage hormone receptor-positive breast cancer that grew during treatment with other hormonal therapy medicines.

Read our breaking news article.